Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: report of two cases

Yıl 2022, Cilt: 5 Sayı: 2, 51 - 55, 30.09.2022

Yelda Varol , Hilal Özdemir Demirci , Onur Karaman , Tülay Akarca , Diğdem Özbakır

https://doi.org/10.33204/mucosa.1115584

Öz

Tuberculosis is still a serious public health issue in underdeveloped countries. There is presently little clinical experience with the co-existence of tuberculosis and COVID-19 infection, presented as the severe acute respiratory syndrome coronavirus 2 infection, which was first observed in China in December 2019. This case report details the diagnostic and treatment stages of two patients who had active tuberculosis and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.

Anahtar Kelimeler

tuberculosis, covid-19, co-infection

Aktif tüberküloz tedavisi sırasında gelişen COVID-19 enfeksiyonunun tedavi ve prognozu: İki olgu sunumu

Öz

Tüberküloz, az gelişmiş ülkelerde hala ciddi bir halk sağlığı sorunudur. Tüberküloz ve COVID-19 enfeksiyonunun birlikteliği ile ilgili çok az sayıda klinik deneyim mevcuttur. COVID-19 enfeksiyonu ilk kez şiddetli akut solunum sendromu tablosu olarak Çin’de Aralık 2019’da görülmüştür. Bu raporda aktif tüberkülozu ve COVID-19 enfeksiyonu olan iki hastanın tanı ve başarılı olan tedavi aşamaları detaylı olarak sunulmuştur.

Anahtar Kelimeler

tüberküloz, covid-19, koenfeksiyon

Kaynakça

• World Health Organization. Global tuberculosis report 2020.
• https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/ Accessed 28.09.2022.
• https://covid19.saglik.gov.tr/ Accessed 28.09.2022.
• Leung CC, Lam TH, Cheng KK. Let us not forget the mask in our attempts to stall the spread of COVID-19. Int J Tuberc Lung Dis 2020;24:364-6.
• Noia Maciel EL, Gonçalves Junior E, Pretti Dalcolmo MM.Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude 2020;29:e2020128.
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
• Chen Y, Wang Y, Fleming J, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedrxivmedRxiv preprint. Mar. 2020. Available at: https://www.medrxiv.org/ content/10.1101/2020.03.10.20033795v1.full.pdf. Accessed 28.09.2022.
• Tadolini M, Codecasa LR, Garcia-Garcia JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.